In other rodent models of obesity, using either angiotensin-converting enzyme (ACE) inhibitors or AT1-specific antagonists increased drinking significantly with an associated decrease in food intake and body weight mainly through loss of fat. This evidence concerns the gene ACE and obesity due to melanocortin 4 receptor deficiency.